• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原纤维蛋白聚糖作为神经退行性疾病中脂质代谢的新兴调节因子。

PGRN as an emerging regulator of lipid metabolism in neurodegenerative diseases.

作者信息

Shi Yiyue, Hou Wenyu, Li Bei, Zhu Caihong

机构信息

School of Basic Medical Sciences, Fudan University, Shanghai, China.

Shanghai Key Laboratory for Acupuncture Mechanism and Acupoint Function, Fudan University, Shanghai, China.

出版信息

Commun Biol. 2025 Jun 2;8(1):844. doi: 10.1038/s42003-025-08272-9.

DOI:10.1038/s42003-025-08272-9
PMID:40456955
Abstract

Dysregulated lipid metabolism in microglia represents a hallmark of neuroinflammation and is often observed in a variety of neurodegenerative diseases. The exact molecular mechanisms underlying the induction of altered lipid homeostasis and how it contributes to neurodegeneration remain to be deciphered. Progranulin (PGRN) is a lysosomal glycoprotein encoded by GRN. Loss-of-function mutations or variants of GRN have been linked to various neurodegenerative diseases. PGRN has recently been identified as a regulator of lipid droplet formation in microglia. Additionally, PGRN has been reported to interact with various molecules to modulate lysosomal lipid metabolism, including glycerolipids and sphingolipids in neurons. Hence, PGRN deficiency-mediated lipid dysregulation may represent a significant contributing factor to the neuroinflammation and the pathogenesis of related neurodegenerative diseases. Understanding how PGRN regulates lipid metabolism is crucial for developing therapeutic strategies to restore lipid homeostasis in microglia and mitigate neuroinflammation, thus offering hope for effective treatments to combat these neurodegenerative disorders in the future.

摘要

小胶质细胞中脂质代谢失调是神经炎症的一个标志,并且在多种神经退行性疾病中经常观察到。脂质稳态改变的诱导背后的确切分子机制以及它如何导致神经退行性变仍有待阐明。前颗粒蛋白(PGRN)是一种由GRN编码的溶酶体糖蛋白。GRN的功能丧失突变或变异与各种神经退行性疾病有关。PGRN最近被确定为小胶质细胞中脂滴形成的调节因子。此外,据报道PGRN与各种分子相互作用以调节溶酶体脂质代谢,包括神经元中的甘油脂质和鞘脂。因此,PGRN缺乏介导的脂质失调可能是神经炎症和相关神经退行性疾病发病机制的一个重要促成因素。了解PGRN如何调节脂质代谢对于制定恢复小胶质细胞脂质稳态和减轻神经炎症的治疗策略至关重要,从而为未来对抗这些神经退行性疾病的有效治疗带来希望。

相似文献

1
PGRN as an emerging regulator of lipid metabolism in neurodegenerative diseases.原纤维蛋白聚糖作为神经退行性疾病中脂质代谢的新兴调节因子。
Commun Biol. 2025 Jun 2;8(1):844. doi: 10.1038/s42003-025-08272-9.
2
Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases.小胶质细胞颗粒蛋白:在阿尔茨海默病和神经退行性疾病中的作用。
Cells. 2019 Mar 11;8(3):230. doi: 10.3390/cells8030230.
3
Progranulin in neurodegenerative dementia.颗粒蛋白前体在神经退行性痴呆中的作用。
J Neurochem. 2021 Jul;158(2):119-137. doi: 10.1111/jnc.15378. Epub 2021 May 28.
4
Progranulin as a therapeutic target in neurodegenerative diseases.颗粒蛋白前体作为神经退行性疾病的治疗靶点。
Trends Pharmacol Sci. 2022 Aug;43(8):641-652. doi: 10.1016/j.tips.2021.11.015. Epub 2022 Jan 15.
5
Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations.脑蛋白质组中颗粒蛋白前体缺失的网络分析揭示了由 GRN 突变引起的人类额颞叶痴呆的共同发病机制。
Acta Neuropathol Commun. 2020 Oct 7;8(1):163. doi: 10.1186/s40478-020-01037-x.
6
Microglia regulate brain progranulin levels through the endocytosis/lysosomal pathway.小胶质细胞通过内吞/溶酶体途径调节大脑中的颗粒蛋白水平。
JCI Insight. 2021 Nov 22;6(22):e136147. doi: 10.1172/jci.insight.136147.
7
Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice.早发性溶酶体成熟缺陷触发颗粒蛋白前体基因敲除小鼠其他脑细胞溶酶体活性增强。
Mol Neurodegener. 2018 Sep 4;13(1):48. doi: 10.1186/s13024-018-0281-5.
8
The lysosomal function of progranulin, a guardian against neurodegeneration.颗粒蛋白前体的溶酶体功能,神经退行性变的守护者。
Acta Neuropathol. 2018 Jul;136(1):1-17. doi: 10.1007/s00401-018-1861-8. Epub 2018 May 9.
9
Microglial progranulin differently regulates hypothalamic lysosomal function in lean and obese conditions via cleavage-dependent mechanisms.小胶质细胞前颗粒蛋白通过裂解依赖性机制在瘦素和肥胖状态下对下丘脑溶酶体功能进行不同调节。
J Neuroinflammation. 2025 Mar 7;22(1):68. doi: 10.1186/s12974-025-03370-1.
10
Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic.用具有脑穿透性的颗粒蛋白前体生物学制剂拯救由 Grn 功能丧失引起的溶酶体贮积症。
Cell. 2021 Sep 2;184(18):4651-4668.e25. doi: 10.1016/j.cell.2021.08.002. Epub 2021 Aug 26.

本文引用的文献

1
Granulins rescue inflammation, lysosome dysfunction, lipofuscin, and neuropathology in a mouse model of progranulin deficiency.颗粒蛋白在颗粒前体蛋白缺乏的小鼠模型中可挽救炎症、溶酶体功能障碍、脂褐素和神经病理学。
Cell Rep. 2024 Dec 24;43(12):114985. doi: 10.1016/j.celrep.2024.114985. Epub 2024 Nov 19.
2
PLD3 and PLD4 synthesize S,S-BMP, a key phospholipid enabling lipid degradation in lysosomes.PLD3 和 PLD4 合成 S,S-BMP,一种关键的磷脂,可使溶酶体中的脂质降解。
Cell. 2024 Nov 27;187(24):6820-6834.e24. doi: 10.1016/j.cell.2024.09.036. Epub 2024 Oct 17.
3
Lysosomal TMEM106B interacts with galactosylceramidase to regulate myelin lipid metabolism.
溶酶体 TMEM106B 与半乳糖脑苷脂酶相互作用,调节髓鞘脂质代谢。
Commun Biol. 2024 Sep 5;7(1):1088. doi: 10.1038/s42003-024-06810-5.
4
Cellular communities reveal trajectories of brain ageing and Alzheimer's disease.细胞群落揭示了大脑衰老和阿尔茨海默病的发展轨迹。
Nature. 2024 Sep;633(8030):634-645. doi: 10.1038/s41586-024-07871-6. Epub 2024 Aug 28.
5
Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson's disease.系统罕见变异分析确定 RAB32 为家族性帕金森病的易感基因。
Nat Genet. 2024 Jul;56(7):1371-1376. doi: 10.1038/s41588-024-01787-7. Epub 2024 Jun 10.
6
Senescent glia link mitochondrial dysfunction and lipid accumulation.衰老的神经胶质细胞将线粒体功能障碍与脂质积累联系起来。
Nature. 2024 Jun;630(8016):475-483. doi: 10.1038/s41586-024-07516-8. Epub 2024 Jun 5.
7
Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration.穿透血脑屏障的颗粒蛋白前体在外周的表达可挽救额颞叶痴呆模型小鼠的病变。
Sci Transl Med. 2024 Jun 5;16(750):eadj7308. doi: 10.1126/scitranslmed.adj7308.
8
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results.颗粒蛋白前体 AAV 基因治疗额颞叶痴呆:转化研究和 1/2 期试验中期结果。
Nat Med. 2024 May;30(5):1406-1415. doi: 10.1038/s41591-024-02973-0. Epub 2024 May 14.
9
Microglial lipid droplet accumulation in tauopathy brain is regulated by neuronal AMPK.tau 病脑中的小胶质细胞脂滴积累受神经元 AMPK 调节。
Cell Metab. 2024 Jun 4;36(6):1351-1370.e8. doi: 10.1016/j.cmet.2024.03.014. Epub 2024 Apr 23.
10
Cognitively healthy centenarians are genetically protected against Alzheimer's disease.认知健康的百岁老人在基因上受到保护,免受阿尔茨海默病的影响。
Alzheimers Dement. 2024 Jun;20(6):3864-3875. doi: 10.1002/alz.13810. Epub 2024 Apr 18.